RR Research

Agilent Technologies, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Agilent Technologies, Inc. - SWOT Analysis examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Agilent Technologies (Agilent) is a measurement company engaged in providing bio-analytical and electronic measurement solutions. The company operates in the US, China, Germany, India, Japan, Malaysia, Singapore, and the UK. It is headquartered in Santa Clara, California and employs about 16,800 people. The company recorded revenues of ,481 million during the financial year ended October 2009 (FY2009), a decrease of 22.4% compared to FY2008. The operating profit of the company was million during FY2009, a decrease of 94.1% compared to FY2008. The net loss was in FY2009 as compared to a net profit of 3 million in FY2008. Scope of the Report - Provides all the crucial information on Agilent Technologies, Inc. required for business and competitor intelligence needs - Contains a study of the major internal and external factors affecting Agilent Technologies, Inc. in the form of .. more»

Report description Technological innovations in the medical device industry have led to a radical transformation in patient care. This report identifies the sectors with the industry's most important developments related to patient care, clinical outcomes, and new product development. While the scope of the report is limited to the top ten technologies only, it covers almost the entire medical device market. Scientific and medical technology breakthroughs – such as minimally invasive surgery (MIS) – have accelerated the accuracy of clinical outcomes and have also reduced recovery times and the medical costs borne by patients. This has led to radical transformation in patient care. IT integration in medical imaging and medical devices has given a significant boost to the healthcare industry, a trend that is apparent in the market growth of drug eluting stents and telemedicine technologies. The markets covered in the report have a current potential of 4.3 billion and are expected to grow at a CAGR of 9.8% between 2009 and 2014. Market estimates and forecast The report provides in-depth market estimates and forecast for top ten medical device technologies as follows: • .. more»